Bioextrax AB (publ) (STO:BIOEX)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.580
+0.040 (1.57%)
Jun 3, 2026, 5:15 PM CET

Bioextrax AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11.563.9317.2713.427.538.98
Cash & Short-Term Investments
11.563.9317.2713.427.538.98
Cash Growth
-4.73%-77.23%28.87%-51.33%206.69%337.54%
Accounts Receivable
-0.03--0.030.12
Other Receivables
0.550.790.730.711.270.79
Receivables
0.550.810.730.711.30.91
Prepaid Expenses
1.260.290.290.290.340.22
Other Current Assets
-0.50.910.361.231.31
Total Current Assets
13.375.5419.214.7630.411.42
Property, Plant & Equipment
5.645.846.827.767.491.22
Other Long-Term Assets
-13.342.98-0.03-
Total Assets
1924.732922.5237.9212.64
Accounts Payable
0.361.181.531.333.562.22
Accrued Expenses
1.280.990.930.440.981.04
Current Income Taxes Payable
---0.140.130.06
Current Unearned Revenue
----0.590.891.41
Other Current Liabilities
0.471.350.470.670.60.41
Total Current Liabilities
2.113.512.941.986.155.14
Total Liabilities
2.113.512.941.986.155.14
Common Stock
2.42.021.971.471.280.74
Additional Paid-In Capital
-12.1422.329.8641.7315.96
Retained Earnings
14.496.681.739.21-11.24-9.2
Comprehensive Income & Other
-0.380.05--0
Shareholders' Equity
16.8921.2226.0620.5431.777.5
Total Liabilities & Equity
1924.732922.5237.9212.64
Net Cash (Debt)
11.563.9317.2713.427.538.98
Net Cash Growth
-4.73%-77.23%28.87%-51.33%206.69%337.54%
Net Cash Per Share
0.280.100.520.511.630.67
Filing Date Shares Outstanding
45.9940.0339.1229.2325.4614.75
Total Common Shares Outstanding
45.9940.0339.1229.2325.4614.75
Working Capital
11.252.0316.2612.7824.256.28
Book Value Per Share
0.370.530.670.701.250.51
Tangible Book Value
16.8921.2226.0620.5431.777.5
Tangible Book Value Per Share
0.370.530.670.701.250.51
Machinery
-10.149.999.778.641.9